Dale Lee Bixby, MD, PhD

Specialty: Hematology, Medical Oncology, Internal Medicine
Title: Clinical Professor
5/5
See All Ratings

To request an appointment call

734-647-8902
Dale Lee Bixby, MD, PhD
Hematology
  • About
  • Areas of Practice
  • Expertise
  • Locations
  • Insurance
  • Education & Training
  • Research Overview
  • Manage Your Profile

  • About

    Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies.

    Areas of Practice

    Adult acute and chronic leukemias, myelodysplastic syndromes, and bone marrow failure disorders.

    Locations

    • Leukemia Clinic | C. S. Mott Children's Hospital 1540 E Hospital Dr
      Floor 7 Reception B
      Ann Arbor, MI 48109-4257
      Get Directions

    Insurance Accepted

    University of Michigan Health participates with most health insurance plans.

    See our insurance details

    Education & Training

    Medical School or Training

    University of Michigan Medical School, 2003

    Residency

    University of Michigan Health System, Internal Medicine, 2006

    Fellowships

    University of Michigan Health System, Internal Medicine Hematology Oncology, 2009

    Board Certifications

    Hematology

    Research Overview

    I conduct and supervise phase clinical trials for therapies for patients with acute leukemias and myelodysplastic syndrome. It is our mission to develop new medications for patients with these disorders.